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Abstract
Objective: Myocardial infarction resulting from ischemia-reperfusion injury can be reduced by cardiac postconditioning, in
which blood flow is restored intermittently prior to full reperfusion. Although key molecular mechanisms and prosurvival
pathways involved in postconditioning have been identified, a direct role for eNOS-derived NO in improving regional
myocardial perfusion has not been shown. The objective of this study is to measure, with high temporal and spatial
resolution, regional myocardial perfusion during ischemia-reperfusion and postconditioning, in order to determine the
contribution of regional blood flow effects of NO to infarct size and protection.
Methods and Results: We used myocardial contrast echocardiography to measure regional myocardial blood flow in mice
over time. Reperfusion after myocardial ischemia-reperfusion injury is improved by postconditioning, as well as by
phosphomimetic eNOS modulation. Knock-in mice expressing a phosphomimetic S1176D form of eNOS showed improved
myocardial reperfusion and significantly reduced infarct size. eNOS knock-out mice failed to show cardioprotection from
postconditioning. The size of the no-reflow zone following ischemia-reperfusion is substantially reduced by
postconditioning and by the phosphomimetic eNOS mutation.
Conclusions and Significance: Using myocardial contrast echocardiography, we show that temporal dynamics of regional
myocardial perfusion restoration contribute to reduced infarct size after postconditioning. eNOS has direct effects on
myocardial blood flow following ischemia-reperfusion, with reduction in the size of the no-reflow zone. These results have
important implications for ongoing clinical trials on cardioprotection, because the degree of protective benefit may be
significantly influenced by the regional hemodynamic effects of eNOS-derived NO.
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Introduction
Ischemic postconditioning is a modified form of reperfusion that
results in reduced myocardial tissue damage [1,2]. Postcondition-
ing represents a particularly attractive therapy against myocardial
ischemia/reperfusion (I/R) injury because it does not require
foreknowledge of the ischemic event. The mechanisms underlying
cardioprotection from postconditioning and preconditioning have
been reviewed recently [3,4,5,6,7], and involve adenosine receptor
signaling, and activation of pro-survival kinase pathways including
ERK1/2, Akt/PI3 kinase, and STAT3. These pathways result in
cellular changes, including activation of mitochondrial ATP-
dependent K channels and inhibition of mitochondrial perme-
ability transition pore opening, resulting in reduction in tissue
damage. Beneficial effects from cardiac postconditioning have
been shown in acute MI patients undergoing PCI [8,9,10,11,12].
Larger clinical trials are now underway for both postconditioning
itself and for pharmacologic agents based on its underlying
cardioprotective pathways [5,7,13,14,15]. eNOS and NO are
involved in cardiac postconditioning signaling [16,17,18,19,20].
However, a direct role for eNOS in modulating regional
myocardial blood flow during reperfusion has not been demon-
strated.
Previous methods for measuring myocardial blood flow in mice
do not have sufficient temporal or spatial resolution to follow
regional myocardial perfusion following I/R injury. We used
myocardial contrast echocardiography (MCE) of intravenously
infused echogenic microbubbles to monitor blood flow in vivo in
mice [21,22]. Here, we use MCE to dynamically track regional
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myocardial blood flow during I/R to understand the mechanisms
of postconditioning protection.
We use wild-type C57BL/6 mice, eNOS knockout mice, and
eNOS mutant mice carrying a single amino acid mutation at the
serine 1176 phosphorylation site (S1176D) [23]. Phosphorylation
of eNOS at this serine (corresponding to serine 1177 in man)
increases eNOS enzymatic activity and NO production [24,25]. In
S1176D mice, the codon for serine is replaced by one encoding
aspartate to achieve a phosphomimetic gain-of-function mutation.
Our current results demonstrate that postconditioning is
characterized by improved regional myocardial blood flow after
I/R, and by an increase in eNOS S1176 phosphorylation.
Further, the phosphomimetic eNOS mutation by itself improves
blood flow and reduces infarct size. In contrast, eNOS knockout
mice do not show reduction in infarct size or improvements in
blood flow following postconditioning. These results reveal the
importance of improved myocardial perfusion as a mechanism for
protection from postconditioning. Further, they demonstrate that
modulation of eNOS phosphorylation influences myocardial
reperfusion, affecting tissue outcome from cardioprotection.
Materials and Methods
Animals
eNOS knockout mice and eNOS S1176D mutant mice were
generated and genotyped as previously described [23,26]. C57BL/
6 mice (Jackson Laboratories) were used as wild-type controls. All
animals were on C57BL/6 genetic background and 8–12 weeks at
the time of the experiments.
Ethics Statement
Experiments were approved by the Massachusetts General
Hospital Institutional Animal Care and Use Committee (Permit
2003-N000297). All surgery was performed under sodium
pentobarbital and ketamine anesthesia, and all efforts were made
to minimize suffering.
Nitrite/nitrate assay
eNOS enzymatic activity was assessed by measurement of
nitrite and nitrate in myocardial tissue using a fluorometric assay
(BioVision). Tissue samples were lysed for 10 minutes on ice with
300ml of tissue-lysis buffer. Tissue homogenates were centrifuged
at 10,000 g for 5 minutes at 4uC and further filtered through a
10 kDa MW cut-off filter (BioVision). Filtrate was collected for the
NO assay.
In vivo myocardial ischemia reperfusion model
Animals were anesthetized with sodium pentobarbital (50 mg/
kg ip) and ketamine hydrochloride (50 mg/kg ip). Depth of the
anesthesia was moni-tored by tail pinch, respiratory rate and heart
rate. Mice were intubated and ventilated. Left anterior descending
coronary artery (LAD) ligation was performed through a
thoracotomy. A 7-0 silk ligature was passed under-neath the
vessel and through a custom snare to induce ischemia without
damaging the artery. Ischemia was achieved by tightening the
snare for 45 minutes and occlusion was confirmed by observed
blanching of the anterior left ventricular wall. After 45 minutes,
the myocardium was reperfused with one of two algorithms 1)
traditional myocardial ischemia-reperfusion (MIR) injury where
the ligation was simply released or, 2) myocardial ischemia
reperfusion with postconditioning (MIPc) where six cycles of 10 sec
reperfusion was followed by 10 sec of ischemia. Buprenorphine
HCl (0.05–0.1 mg/kg) was administered post-operatively.
Infarct size determination
After 24 hour reperfusion, the LAD was religated with 7-0 silk
suture, and 1 ml of 1% Evans blue was perfused retrograde
through the left carotid artery to delineate the area at risk (AAR).
The heart was excised and fixed in a 2% solution of agarose gel
and allowed to solidify. Myocardial tissue was sectioned into 1-
mm-thick axial sections. Infarct size was determined by staining
with 2,3,5-triphenyltetrazolium chloride (TTC) for 20 minutes in
the dark at 37uC. Each sliced was weighed and photographed
through a dissecting microscope. The left ventricular area, AAR,
and area of infarction for each slice were determined by
planimetry. The final size of infarction was determined by
integrating the infarct areas in each myocardial slice over the
entire myocardium as previously described [27].
Western blot analysis
Myocardial tissues were harvested after 45 min ischemia and 10
min reperfusion. The left ventricular AAR was identified by
blanched myocardium during ischemia. Myocardial tissues were
homogenized to obtain protein extracts and 100mg of protein was
subjected to electrophoresis in 7% Tris-HCl polyacrylamide gels.
Proteins were transferred to PDVF membranes for Western blot
analysis and visualized by chemiluminescence. Antibodies to
eNOS (Sigma-Aldrich), phospho-eNOS (p-Ser1177 human se-
quence numbering, BD Bioscience), Akt (Cell Signaling) and
phospho-Akt (p-Ser473, Cell Signaling) were obtained commer-
cially.
Myocardial contrast echocardiography
MCE studies were performed as previously described [22]. Mice
were anesthetized with intraperitoneal injections of sodium
pentobarbital (50 mg/kg) and ketamine hydrochloride (50 mg/
kg). Heart rate and blood pressure were monitored through a
carotid catheter and recorded with a blood pressure analysis
module in PowerLab (ADInstruments). A venous line was placed
in the left jugular vein for constant infusion of microbubbles. 10%
Perflutren lipid microspheres (Definity, Lantheus Imaging) were
diluted tenfold in sterile saline and infused intravenously at 20mL/
min. A thoracotomy was performed to provide unobstructed
visualization of the myocardium. A 7-0 silk suture was passed
underneath the LAD and through a custom snare. MCE was
performed with a 14 MHz linear transducer using an Acuson
Sequoia C512 system, using a mechanical index of 0.24. Perfusion
images were obtained in real time following destruction of
microbubbles using a sequence of 10 high-energy frames
(mechanical index 1.9). Signal intensity was obtained for 10
seconds after the high-energy sequence at a frame rate of 30 Hz.
Parasternal long-axis views were recorded at the level of the aortic
arch. For temporal monitoring of myocardial blood flow MCE was
used to measure blood flow at baseline before ischemia, during
ischemia, and at 5, 10, 30 minutes after initiation of reperfusion.
Myocardial perfusion analysis
MCE was performed on the anteroseptal wall in the parasternal
long-axis view using methods previously described [22]. Detection
and segmentation of the left ventricular septum was accomplished
using a shape based snake model of edge detection in Matlab
(Mathworks) [28,29]. The anterior septum was divided into three
regions of interest defined by the apical septum, mid septum and
basal septum. Average signal intensity within each region of
interest was measured in each frame and a curve of signal intensity
over time was fitted to an exponential function: y = A (1 – e2b t),
where y is the signal intensity, b is the initial slope of the curve and
eNOS and Cardiac Postconditioning
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A is the signal plateau intensity. Two to three curves were
averaged per time-point for each animal. Myocardial blood flow
was estimated by the product of Ab. Values are expressed as
percentage of baseline Ab.
No-reflow analysis
MCE measurements were taken at baseline as a measure of
myocardial blood flow before ischemia and compared against
MCE measurements taken at the end of the study, 30 minutes
after reperfusion. Three consecutive MCE images were averaged
for each animal under each condition, the average signal intensity
of the left ventricular anteroseptum at baseline was calculated.
Images were converted to relative myocardial blood flow images
by using a thresholding paradigm to identify areas of severe (0%–
20% residual blood flow, representing the core ischemic region)
and moderate (21%–30% residual blood flow, representing
penumbra) blood flow relative to baseline [30].
Statistics
All results are expressed as mean 6 SD, except western blot
densities which are expressed as mean 6 SEM. Statistical analysis
was performed in Matlab (Mathworks) using Kriskal-Wallis
analysis of variance and Wilcoxon rank-sum tests with Bonfer-
onni’s correction. Differences of P,0.05 were considered signif-
icant.
Results
Postconditioning and S1179D mice show protection
from I/R injury in vivo
We examined the response to myocardial I/R injury in wild-
type mice, S1176D mice, and eNOS knockout mice by ligation of
the left anterior descending (LAD) artery for 45 minutes, followed
by reopening of the ligated vessel. We compared the response of
animals subjected to myocardial ischemia reperfusion alone (MIR)
with those subjected to myocardial ischemia reperfusion with
postconditioning (MIPc), using a pattern of 6 cycles of 10 sec
reperfusion followed by 10 sec ischemia. The areas at risk,
determined 24 hours after I/R, were not significantly different
across groups (Figure 1A). WT mice subjected to MIPc developed
smaller infarcts (ratio of infarct size/area at risk) compared to mice
subjected to MIR (Figure 1B left). S1176D mice displayed smaller
infarcts in both MIR and MIPc groups (Figure 1B middle). The
reduced infarct sizes in S1176D ki mice were comparable to those
seen in postconditioned WT mice. eNOS ko mice showed no
reduction in infarct size from postconditioning (Figure 1B right).
Representative infarct slices with the infarct zones outlined are
shown in Figure 1C.
eNOS protein levels and enzymatic activity in mutant
mice
Total eNOS protein levels were the same in the hearts of WT
and S1176D mice, and eNOS was not detectable in the hearts of
eNOS ko mice (Figure 2A). However, eNOS enzymatic activity, as
reflected by fluorometric determination of nitrate/nitrite stable
breakdown products of NO metabolism, was greater in heart tissue
of S1176D mice than of WT mice (3.2 pmol/mg tissue vs. 2.5+/–
0.6 pmol/mg tissue, p= 0.03), consistent with results from other
tissues [23]. Thus, baseline levels of eNOS enzymatic activity and
NO in the myocardium can be regulated by phosphomimetic
modulation of the S1176 phosphorylation site.
Postconditioning activates Akt and eNOS
We determined the expression levels and degree of phosphor-
ylation of Akt and eNOS following in response to myocardial I/R
injury. Figure 2B shows the effects of MIR and MIPc on eNOS
phosphorylation, all in WT mice. MIR diminishes eNOS
phosphorylation at S1176, while MIPc does not. Figure 2C shows
the effects of I/R and postconditioning on Akt phosphorylation.
Akt phosphorylation at S473 was higher in wild-type mice after
MIPc than MIR alone. In wild-type mice, these changes are
associated with parallel changes in eNOS phosphorylation at
S1176 (Figure 2B). In S1176D mice, the level of Akt phosphor-
ylation did not change with MIR or MIPc (Figure 2C, middle). In
eNOS knockout mice, Akt phosphorylation was increased
following MIPc (Figure 2C, right), though this increase, in the
absence of eNOS, did not result in cardioprotection (Figure 1B,
right). The reasons for increased Akt phosphorylation in eNOS ko
mice is not known but possibilities include positive feedback
between eNOS phosphorylation and phosphorylation of Akt
kinase itself.
Postconditioning eNOS and S1176 phosphorylation are
associated with improved regional myocardial perfusion
kinetics
We used MCE to dynamically track regional myocardial blood
flow [21,22] during MIR and MIPc. Wild-type, eNOS knockout,
and S1176D mice were subjected to 45 min LAD ligation and
reperfusion, without (MIR) and with postconditioning (MIPc) to
determine whether improvements in regional myocardial blood
flow could contribute to cardioprotection. We obtained high
quality two-dimensional parasternal long-axis images of the
myocardium to follow regional myocardial perfusion (Figure 3A).
The anterior septum was divided into three regions to capture the
distinct blood flow changes in each anatomic region. Region
1,outlined in red, is the basal anteroseptum. Region 2, outlined in
blue, is the mid anteroseptum. Region 3, outlined in black, is the
apical septum. The site of LAD ligation is located between regions
2 and 3. The majority of blood flow deficits are found in the apical
septum.
After contrast containing microbubbles are introduced into the
circulation, the bubbles are synchronously destroyed in the field of
view, and their reappearance is quantitated over time in specific
regions. Two parameters describe regional perfusion. The first
parameter is A, the steady state level (plateau) of the microbubbles
(see Figure 3D). The second parameter is b, that rate of
reappearance (slope) of microbubbles following synchronous
destruction [31]. Regional myocardial blood flow was estimated
by the product of these two parameters (Ab) [22,32].
In wild-type mice (Figure 3D, top row), baseline blood flow (left
panel) in all three regions is comparable. With MIR (middle
panel), perfusion was markedly impaired in the apical septum
(black, arrow) in the region corresponding to the eventual infarct.
With MIPc, (right panel), perfusion in the apical septum (black) is
improved over with MIR. These results show that MIPc is
associated with improvements in the restoration of regional blood
flow in the ischemic zone.
In eNOS knockout mice (Figure 3D, middle row), baseline
blood flow (left panel) in all three regions is comparable, and
similar to those seen in wild-type mice. With MIR, regional blood
flow is reduced in both the mid-septum (blue) and apical septum
(black). With MIPc, the blood flow in these regions continues to be
poor, and is even worse than with MIR. These results show that
eNOS knockout mice have more pronounced regional perfusion
eNOS and Cardiac Postconditioning
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defects than wild-type mice, and unlike wild-type mice, they show
no improvements in regional blood flow with postconditioning.
In contrast, S1176D mice (Figure 3D, bottom row) showed
robust tolerance against myocardial blood flow deficit caused by
MIR. Replenishment curves from both MIR (middle panel) and
MIPc (right panel) groups showed minimal deficits in myocardial
blood flow. These results indicate that the phosphomimetic eNOS
mutation by itself is associated with improved restoration of
regional perfusion.
To extend our understanding of the temporal dynamics of the
apical blood flow deficits associated with MIR and MIPc, we
performed MCE serially over the time-course of reperfusion.
Figure 4 shows temporal MCE profiles in the apical septum for
wild-type, eNOS knockout, and S1176D mice. Blood flow
measurements were normalized to myocardial blood flow values
at baseline. Wild-type mice subjected to MIR exhibited worsening
myocardial blood flow over time, whereas WT mice subjected to
MIPc showed improvement in myocardial blood flow, with
significantly improved perfusion after 30 minutes (Figure 4A).
eNOS knockout mice showed worsening myocardial blood flow
over time with both MIR and MIPc, with no detectable difference
at 30 minutes (Figure 4B). Although the 1 minute timepoint shows
a higher blood flow in the S1176D mice (Figure 4B) than in the
WT mice (Figure 4A0, this early difference did not translate to
improvement in blood flow at 30 minutes, nor was there a
difference between MIR and MIPc groups. S1176D mice show
rapid return to pre-ischemic levels of perfusion and higher with
both MIR and MIPc (Figure 4C). Quantitation of the myocardial
blood flow in the apical septum at 30 minutes of reperfusion
(Figure 4D) shows that MIPc is associated with improvement in
reperfusion in wild-type mice. eNOS knockout mice fail to show
reperfusion with either MIR or MIPc. S1176D mice show robust
reperfusion with both MIR and MIPc. The temporal results from
MCE analysis support the notion that increased phosphomimetic
eNOS activity enhances myocardial blood flow after I/R injury.
Mean arterial pressure and heart rate were monitored throughout
the course of I/R and no significant difference was found between
groups (data not shown).
Assessment of myocardial no-reflow zones
Despite opening of an infarct-related artery, no-reflow zones
may result from persistent perfusion defects. These are thought to
be caused by obstructed or dysfunctional capillaries in the
microvasculature caused by endothelial dysfunction. We assessed
the spatial extent of no-reflow zones using MCE, defined as
regions with severe blood flow reductions to less than 20% of
baseline blood flow [33]. As shown in Figure 5, wild-type mice
developed larger no-reflow zones at the 30 minute timepoint after
MIR than after MIPc. eNOS knockout mice showed large no-
reflow zones comparable to wild-type mice treated with MIR.
S1176D mice showed significantly smaller no-reflow zones with
both MIR and MIPc.
Discussion
Much of the clinical treatment of acute myocardial infarction
focuses on restoring coronary artery blood flow through the infarct
vessel, either through pharmacologic agents (thrombolysis, anti-
Figure 1. eNOS S1176 phosphorylation protects against I/R injury in vivo. Wild-type, S1176D and eNOS knockout mice were subjected to
45 minutes of myocardial ischemia (LAD ligation) followed by traditional reperfusion (MIR) or postconditioned reperfusion (MIPc: 6 cycles of 10sec
reperfusion, 10 sec ischemia). A. Percentage of left ventricle area at risk (AAR), (P =NS). B. Quantitative analysis of infarct size over AAR, *P,0.05
compared to wild-type control. C. Representative heart sections perfused with 1% Evans blue and stained with 2% TTC; infarct areas are outlined in
black. MIR: Myocardial ischemia with reperfusion, MIPc: Myocardial ischemia with postconditioning, AAR: Area at Risk, LV: Left Ventricle. n = 6–9 mice
per group. Data are expressed as the mean6SD.
doi:10.1371/journal.pone.0085946.g001
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Figure 2. Postconditioning activates Akt and eNOS. A. Western blot of total eNOS and GADPH in WT (C57BL6/J), S1176D mice (S1176ki), and
eNOS ko mice. B. Western blot demonstrating phosphorylation (Ser1176) and total protein levels of eNOS in wild-type mice under conditions of
control (CTL), MIR, and MIPc. C. Representative Western blot demonstrating phosphorylated (Ser473) and total protein levels of Akt. Densities
(arbitrary units, AU) show that MIPc phosphorylates Akt in WT and eNOS ko mice. n = 5 per group. Data are expressed as the mean6SD. *P,0.05.
doi:10.1371/journal.pone.0085946.g002
Figure 3. MCE of regional blood flow following I/R. A. The left ventricular septum in the parasternal long axis view was divided into three
regions of interest: apical septum (black), mid septum (blue) and basal septum (red). RV: Right ventricle, RA: Right atrium, LV: Left ventricle.
Representative MCE image taken at baseline, B. Representative MCE image during ischemia. C. Representative MCE image 30 minutes after
reperfusion. D. Analysis of regional change in myocardial perfusion. Representative region-specific replenishment curves 30 minutes post-reperfusion
are shown: apical septum (black), mid septum (blue), and basal septal regions (red). Replenishment curves are characterized by the myocardial blood
flow parameters A (plateau intensity) and b (flow velocity).
doi:10.1371/journal.pone.0085946.g003
eNOS and Cardiac Postconditioning
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Figure 4. Temporal myocardial contrast echocardiography. Myocardial blood flow (Ab) profiles in the apical region for A. C57BL/6J mice. B.
eNOS knockout mice, and C. S1176D knockin mice. Levels of myocardial myocardial blood flow were normalized to baseline values and measured at
2, 10 and 30 minutes after reperfusion. D. Apical myocardial blood flow 30 minutes after reperfusion. MIR: Traditional myocardial ischemia with
reperfusion, MIPc: Myocardial ischemia with postconditioning. n = 5–6 per group. Data are expressed as the mean6SD. *P,0.05.
doi:10.1371/journal.pone.0085946.g004
Figure 5. Effect of postconditioning and S1176D mutation on no-reflow zones. A. Representative images 30 minutes after reperfusion.
Superimposed areas (blue) indicate regions with #20% residual blood flow. B. Composite graph showing areas of the myocardium with #20%
(black) and #30% (white) residual blood flow compared to preischemic baseline. MBF: myocardial blood flow. n = 5–6 per group. Data are expressed
as the mean6SD. *P,0.05.
doi:10.1371/journal.pone.0085946.g005
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platelet agents) or mechanical means (percutaneous coronary
intervention or coronary artery bypass graft surgery). However,
reperfusion following ischemia can be associated with significant
tissue damage, due to rapid normalization of pH, Ca2+ overload,
generation of reactive oxygen species, and opening of mitochon-
drial permeability transition pores [6]. Reperfusion injury can be
reduced by cardiac preconditioning and postconditioning para-
digms. Postconditioning is particularly attractive because it does
not require foreknowledge of the ischemic event. The mechanisms
of preconditioning and postconditioning involve the activation of
cardioprotective survival pathways, including ERK1/2 and Akt
kinase (together termed the reperfusion injury salvage kinases or
RISK pathways) and TNFa and STAT3 pathways (together
termed the survival activating factor enhancement or SAFE
pathways). These pathways lead to activation of the mitochondrial
ATP-dependent potassium channel and inhibition of mitochon-
drial permeability transition pore opening, resulting in decreased
cell death [5,6,7,13,34]. eNOS is known to be activated by these
cardioprotective pathways, and is thought to play signaling roles in
mediating postconditioning protection [17,18,19]. Despite its well
known role as an endogenous vasodilator, a direct role for eNOS-
derived NO in improving microvascular regional blood flow after
postconditioning has not been demonstrated.
A unique aspect of the current report is the application of MCE
to delineate regional myocardial blood flow over time during I/R
and postconditioning. Our results show that despite opening of the
infarct artery during reperfusion, MIR results in detectable defects
in microvascular tissue perfusion in the distal septum following
LAD ligation. These defects are less marked following MIPc, with
improved tissue perfusion in the affected area. This establishes that
in addition to cardioprotective signaling mechanisms, differences
in restoration of regional blood flow contribute to the reduction in
infarct size following postconditioning. Furthermore, Western blot
results confirm that MIPc is associated with activation of Akt
kinase and eNOS phosphorylation in wild-type mice. Interestingly,
Akt phosphorylation is still observed in eNOS knockout mice,
although the protective effects of postconditioning are lost in the
absence of eNOS.
eNOS activity is regulated in vivo by a variety of mechanisms
[35,36], including phosphorylation at S1176, resulting in increased
enzymatic activity [24,25]. eNOS phosphorylation is deficient in
diabetes and hyperlipidemia, and may mechanistically contribute
to endothelial dysfunction seen in these conditions. Here, we use
eNOS mutant mice that carry the S1176D gain of function
mutation [23]. We previously showed that this phosphomimetic
mutation rescues impaired blood flow in Akt1 deficient mice
subjected to wound healing assays [37], and improves vessel
reactivity and decreases stroke size when challenged with cerebral
ischemia [38].
eNOS S1176D mice, even without postconditioning, show
tolerance against I/R injury in vivo, comparable to postconditioned
wild-type mice. MCE replenishment curves confirm that restora-
tion of myocardial reperfusion in the area at risk is significantly
improved in S1176D mice as compared with wild-type mice, both
with MIR and MIPc. In contrast, eNOS knockout mice do not
show any improvement from postconditioning, and MCE
replenishment curves show more pronounced defects in reperfu-
sion, not only in the apical septum, but also in the mid-septum
when compared with wild-type mice.
The no-reflow zone is reduced by postconditioning in wild-type
mice, but not in eNOS knockout mice. The no-reflow zone is
markedly reduced in the S1176D mice, both with and without
postconditioning. The finding that Akt phosphorylation is still
increased in eNOS knockout mice by MIPc, while postcondition-
ing protection is not observed, suggests that eNOS activity is
required for the protective effects of Akt pathway activation.
Further, these results suggest that effects on regional microvascular
blood flow and reperfusion, mediated by eNOS, may interact with
known cardioprotective mechanisms to modulate tissue outcome,
and that cardioprotection may require a minimum degree of
reperfusion to salvage tissue.
Our results here in eNOS ko mice contrast with a previous
study that showed that eNOS ko mice develop larger infarcts than
do WT mice after cardiac ischemia [27]. These differences are
likely due to the specific experimental protocols used. The MIR
model used here is a severe model of ischemia caused by LAD
ligation for 45 minutes followed by reperfusion for 24 hours.
Infarct size is over 50% of the ischemic zone for both WT and
eNOS ko mice. In contrast, the previous study used a less severe
model, with ischemia for 20 minutes followed by reperfusion for
120 minutes. Infarct size was 20.9% of the ischemic zone for WT
mice, while it was 46% for eNOS ko mice [27].
In summary, our results establish that postconditioning
improves restoration of myocardial blood flow in the area at risk,
and increases eNOS S1176 phosphorylation in wild-type mice.
These results are important because they demonstrate the in vivo
effects of eNOS activity on microvascular blood flow during
reperfusion. In addition to roles for NO in signaling and activation
of pro-survival pathways, our findings reveal that eNOS influences
the degree of myocardial reperfusion following I/R injury. These
new insights suggest that eNOS S1176 activation and regional
reperfusion dynamics could affect the degree of myocardial
survival, relevant not only to postconditioning, but also to
pharmacologic modulation of cardioprotective mechanisms now
in clinical trials.
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